Integer Holdings Co. (NYSE:ITGR) COO Jeremy Friedman sold 8,163 shares of Integer stock in a transaction that occurred on Wednesday, January 3rd. The stock was sold at an average price of $44.89, for a total transaction of $366,437.07. Following the completion of the transaction, the chief operating officer now owns 17,673 shares of the company’s stock, valued at approximately $793,340.97. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.
Jeremy Friedman also recently made the following trade(s):
- On Tuesday, December 12th, Jeremy Friedman sold 11,229 shares of Integer stock. The stock was sold at an average price of $46.01, for a total transaction of $516,646.29.
Integer Holdings Co. (NYSE:ITGR) traded up $1.00 during mid-day trading on Friday, reaching $45.85. 142,646 shares of the company’s stock were exchanged, compared to its average volume of 143,236. The company has a current ratio of 2.58, a quick ratio of 1.37 and a debt-to-equity ratio of 1.95. Integer Holdings Co. has a 12 month low of $29.00 and a 12 month high of $55.20. The firm has a market capitalization of $1,420.00, a PE ratio of 71.64, a P/E/G ratio of 0.95 and a beta of 1.07.
A number of research analysts recently issued reports on the stock. BidaskClub upgraded shares of Integer from a “buy” rating to a “strong-buy” rating in a research note on Thursday, September 28th. ValuEngine upgraded shares of Integer from a “hold” rating to a “buy” rating in a research note on Sunday, December 31st. Zacks Investment Research upgraded shares of Integer from a “sell” rating to a “buy” rating and set a $51.00 price target for the company in a research note on Wednesday, December 27th. Royal Bank of Canada reiterated a “neutral” rating on shares of Integer in a research note on Friday, October 27th. Finally, KeyCorp reiterated an “overweight” rating and issued a $62.00 price target (up previously from $51.00) on shares of Integer in a research note on Monday, September 18th. Four research analysts have rated the stock with a hold rating and three have issued a buy rating to the company. Integer presently has an average rating of “Hold” and an average price target of $51.00.
A number of hedge funds have recently added to or reduced their stakes in the business. First Trust Advisors LP acquired a new position in shares of Integer in the 2nd quarter valued at $771,000. Rhumbline Advisers increased its holdings in shares of Integer by 2.2% in the 2nd quarter. Rhumbline Advisers now owns 60,673 shares of the medical equipment provider’s stock valued at $2,624,000 after acquiring an additional 1,332 shares during the period. Legal & General Group Plc increased its holdings in shares of Integer by 8.1% in the 2nd quarter. Legal & General Group Plc now owns 55,219 shares of the medical equipment provider’s stock valued at $2,389,000 after acquiring an additional 4,156 shares during the period. BNP Paribas Arbitrage SA increased its holdings in shares of Integer by 66.3% in the 2nd quarter. BNP Paribas Arbitrage SA now owns 10,689 shares of the medical equipment provider’s stock valued at $462,000 after acquiring an additional 4,262 shares during the period. Finally, Prudential Financial Inc. increased its holdings in shares of Integer by 27.5% in the 2nd quarter. Prudential Financial Inc. now owns 66,262 shares of the medical equipment provider’s stock valued at $2,866,000 after acquiring an additional 14,275 shares during the period. 95.02% of the stock is currently owned by institutional investors.
TRADEMARK VIOLATION WARNING: This piece was originally reported by American Banking News and is owned by of American Banking News. If you are accessing this piece on another site, it was illegally stolen and republished in violation of US and international trademark and copyright laws. The original version of this piece can be read at https://www.americanbankingnews.com/2018/01/05/integer-holdings-co-itgr-coo-jeremy-friedman-sells-8163-shares.html.
Greatbatch, Inc is a developer and manufacturer of medical devices and components. The Company operates through two segments: Greatbatch Medical and QiG Group (QiG). Greatbatch Medical designs and manufactures products where the Company either owns the intellectual property or has unique manufacturing and assembly expertise.
Receive News & Ratings for Integer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integer and related companies with MarketBeat.com's FREE daily email newsletter.